Mirae Asset Global Etfs Holdings Ltd. Vera Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 28,695 shares of VERA stock, worth $859,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,695
Previous 21,317
34.61%
Holding current value
$859,702
Previous $941,000
28.91%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$168 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$131 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$100 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$88.7 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$88.4 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $810M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...